About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Skin Cancer Screening and Education at Beaches | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDNANCT00894855

Skin Cancer Screening and Education at Beaches

This study was an evaluation of the Dana-Farber Cancer Institute Blum Family Resource Center Van's existing skin cancer screening and education program. This program occurred over 2 summers. This stud...

Lead sponsor: Dana-Farber Cancer Institute•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Dana-Farber Cancer Institute

Collaborators

The Shilling SHADE Foundation of America
University of Massachusetts, Amherst
Harvard Medical School (HMS and HSDM)
Brigham and Women's Hospital

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•Beachgoers eligible to participate in the study included:
•* those who were 18 years and older
•* Caucasian
•* able to understand, speak and read English
•* ability to give informed consent
•* had not already enrolled in the study at another participating beach

Related studies

Alpha Radiation Emitters Device (DaRT) in Combination With Check Point Inhibitor for the Treatment of Recurrent Unresectable or mHNSCC

NCT05047094 · Head and Neck Squamous Cell Carcinoma, Skin Cancer, and more

Early Detection of Skin Tumors Using a Telemedicine Tool in Primary Care

NCT07349940 · Skin Cancer Prevention, Melanoma In Situ, and more

RECRUITINGEARLY Phase 1

Pilot Trial of Supplemental Vitamin A and Nicotinamide

NCT05702398 · Skin Cancer, Kidney Transplant Recipients

RECRUITINGPhase 1/2

Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors

NCT07287917 · Melanoma (Skin Cancer), HER2-low Hormone Receptor Positive Breast Cancer

RECRUITINGPhase 1/2

EBNK-001 Allogeneic NK Cells With Low-Dose IL-15 ± Pembrolizumab in Advanced Solid Tumors

NCT07410676 · Cancer, Sarcoma, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: December 31, 2014Terms

Trial snapshot

StatusCOMPLETED

PhaseNA

Enrollment634

Start dateJan 2007

Last updatedDec 31, 2014

Condition

Locations shown

Dana-Farber Cancer Institute

Boston, Massachusetts

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: December 31, 2014Data synced to Clareo: May 17, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions